Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma-Reference-Cited by-同舟云学术

Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma

Published:2004-02 Issue:3 Volume:90 Page:620-625
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Naumann R,Beuthien-Baumann B,Reiß A,Schulze J,Hänel A,Bredow J,Kühnel G,Kropp J,Hänel M,Laniado M,Kotzerke J,Ehninger G

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6601561.pdf

Reference31 articles.

1. Bangerter M, Moog F, Buchmann I, Kotzerke J, Griesshammer M, Hafner M, Elsner K, Frickhofen N, Reske SN, Bergmann L (1998) Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease. Ann Oncol 9: 1117–1122

2. Brunning RD, Bloomfield CD, McKenna RW, Peterson LA (1975) Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Intern Med 82: 365–366

3. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31: 1860–1861

4. Carde P, Hagenbeek A, Hayat M, Monconduit M, Thomas J, Burgers MJ, Noordijk EM, Tanguy A, Meerwaldt JH, Le Fur R (1993) Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. J Clin Oncol 11: 2258–2272

5. Carr R, Barrington SF, Madan B, O'Doherty MJ, Saunders CA, van der Walt J, Timothy AR (1998) Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood 91: 3340–3346

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathologic Validation of Deauville Score-Based Disease on F-18 FDG PET/CT after First-Line Treatment in Patients with Lymphoma;Nuclear Medicine and Molecular Imaging;2024-06-15

2. ¹⁸F‐FDG‐PET/CT imaging in diagnostic workup of pediatric precursor B‐cell lymphoblastic lymphoma;Pediatric Blood & Cancer;2023-08-28

3. PET/CT in Hodgkin Lymphoma: An Update;Seminars in Nuclear Medicine;2023-05

4. European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours;The Lancet Haematology;2023-05

5. Interim positron emission tomography/computed tomography as a major prognostic factor of treatment outcome in newly diagnosed Hodgkin’s lymphoma and optimization of the therapeutic approach;Medical review;2023